ICD-10 Coding for Autoimmune Hemolytic Anemia(D59.10, D59.10A, D59.10B)
Comprehensive guide to coding autoimmune hemolytic anemia using ICD-10, including warm, cold, and mixed types. Ensure accurate documentation and coding compliance.
Complete code families applicable to Autoimmune Hemolytic Anemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D59.11 | Warm autoimmune hemolytic anemia | Use when documentation specifies warm AIHA with IgG antibodies. |
|
| D59.12 | Cold autoimmune hemolytic anemia | Use when documentation specifies cold agglutinin disease with IgM antibodies. |
|
| D59.13 | Mixed type autoimmune hemolytic anemia | Use when both warm and cold antibodies are documented. |
|
| D59.10 | Autoimmune hemolytic anemia, unspecified | Use when the type of AIHA is not specified in documentation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAutoimmune Hemolytic Anemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Autoimmune Hemolytic Anemia.
Lack of specificity in AIHA type
Impact
Clinical: May lead to inappropriate treatment, Regulatory: Non-compliance with coding standards, Financial: Potential for reduced reimbursement
Mitigation
Educate providers on importance of specifying AIHA type, Implement checklists for documentation
Using D59.10 when specific antibody type is documented
Impact
Reimbursement: May lead to lower reimbursement rates, Compliance: Non-compliance with coding specificity requirements, Data Quality: Decreased accuracy in clinical data
Mitigation
Use D59.11, D59.12, or D59.13 based on antibody type
Specificity in AIHA coding
Impact
Risk of audits due to unspecified AIHA coding
Mitigation
Ensure documentation includes specific antibody type and DAT results